Institute of Nephrology, Zhongda Hospital, Southeast University School of Medicine, Nanjing, Jiangsu, China.
Institute of Nephrology, Zhongda Hospital, Southeast University School of Medicine, Nanjing, Jiangsu, China.
EBioMedicine. 2024 Sep;107:105294. doi: 10.1016/j.ebiom.2024.105294. Epub 2024 Aug 22.
Acute kidney injury (AKI) is a clinical syndrome characterized by a rapid and significant decrease in renal function that can arise from various etiologies, and is associated with high morbidity and mortality. The renal tubular epithelial cells (TECs) represent the central cell type affected by AKI, and their notable regenerative capacity is critical for the recovery of renal function in afflicted patients. The adaptive repair process initiated by surviving TECs following mild AKI facilitates full renal recovery. Conversely, when injury is severe or persistent, it allows the TECs to undergo pathological responses, abnormal adaptive repair and phenotypic transformation, which will lead to the development of renal fibrosis. Given the implications of TECs fate after injury in renal outcomes, a deeper understanding of these mechanisms is necessary to identify promising therapeutic targets and biomarkers of the repair process in the human kidney.
急性肾损伤 (AKI) 是一种以肾功能迅速而显著下降为特征的临床综合征,可由多种病因引起,并伴有高发病率和死亡率。肾小管上皮细胞 (TECs) 是受 AKI 影响的主要细胞类型,其显著的再生能力对受影响患者的肾功能恢复至关重要。轻度 AKI 后存活的 TEC 启动的适应性修复过程有助于完全恢复肾功能。相反,当损伤严重或持续时,它允许 TEC 经历病理反应、异常适应性修复和表型转化,这将导致肾纤维化的发展。鉴于损伤后 TEC 命运对肾脏结局的影响,需要更深入地了解这些机制,以确定人类肾脏修复过程中有希望的治疗靶点和生物标志物。